The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.
Shino MY, Zhang Q, Li N, Derhovanessian A, Ramsey A, Saggar R, Britton IN, Amubieya OO, Lari SM, Hickey M, Reed EF, Noble PW, Stripp BR, Fishbein GA, Lynch JP 3rd, Ardehali A, Sayah DM, Weigt SS, Belperio JA.
Shino MY, et al. Among authors: li n.
Am J Transplant. 2022 Feb;22(2):565-573. doi: 10.1111/ajt.16827. Epub 2021 Nov 12.
Am J Transplant. 2022.
PMID: 34464505
Free PMC article.